@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix Protein: . @prefix sfam: . @prefix geneProductOf: . @prefix rgd: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: sfam:PDGF%20Family; a Protein: . sub:_2 geneProductOf: rgd:69328; a Protein: . sub:_3 rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:_4 occursIn: obo:UBERON_0000947, species:10116; rdf:object sub:_3; rdf:predicate belv:decreases; rdf:subject chebi:50122; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:rosiglitazone) -| (p(SFAM:\"PDGF Family\") -> p(RGD:Cdkn1a))", "p(SFAM:\"PDGF Family\") -> p(RGD:Cdkn1a)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "PPARgamma ligands troglitazone (TRO, 10 microm) and rosiglitazone (RSG, 10 microm) attenuated the induction of p21(Cip1) protein by platelet-derived growth factor (PDGF) and insulin without affecting cognate mRNA levels in rat aortic smooth muscle cells (RASMC)."; prov:wasQuotedFrom pubmed:11598137 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11598137; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:44.145+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }